We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Point-Of-Care Test to Transform Early-Stage Cervical Cancer Diagnosis

By LabMedica International staff writers
Posted on 27 Jun 2025

Cervical cancer is the world’s fourth most common cancer in women. More...

When it’s found early, it’s one of the most preventable and treatable cancers. The main screening method is an in-person Pap smear. The FDA recently approved the first at-home self-collection device, which screens for HPV, the virus that causes nearly all cervical cancers. Still, these methods can be expensive, time-consuming, and not always available. Now, a new method based on measuring cellular proteins could reduce the need for expensive laboratory equipment and training.

Researchers are now one step closer to developing a simple, at-home test to prevent cervical cancer or treat it early, according to a new study by researchers from the University of Florida Health Cancer Center (Gainesville, FL, USA) and Purdue University (West Lafayette, IN, USA). In the new study, researchers validated four proteins that were more abundant in swabs from women with high-grade precancerous lesions and tissue samples from patients. The results, published in the journal Cancers, show that the researchers found the proteins could be used as sensitive and specific biomarkers to indicate precancerous lesions and to distinguish subtypes of cervical cancer.

Precancerous lesions can usually be successfully treated, preventing cancer from developing. Knowing the subtype tells health care providers how aggressive or fast-moving the cancer is, helping them develop a treatment plan. Next, the researchers plan to develop a standardized way to collect and process cervical cancer samples, paving the way for a point-of-care test. Point-of-care tests are portable tests that can be done in more convenient settings than a traditional medical laboratory, and they’re usually faster.

“Our results pave the way for us to develop inexpensive, fast and accurate preliminary screening tests for cervical cancer,” said Sulma Mohammed, D.V.M., Ph.D., the study’s senior author. “This test has the potential to transform early-stage cervical cancer diagnosis and treatment, particularly in areas with limited access to health care.”

Related Links:
UF Health Cancer Center 


New
Gold Member
Latex Test
SLE-Latex Test
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
PSA Assay
CanAg PSA EIA
New
Celiac Disease Test
Anti-Gliadin IgG ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: How the predictive test works (Photo courtesy of QMUL)

World’s First Clinical Test Predicts Best Rheumatoid Arthritis Treatment

Rheumatoid arthritis (RA) is a chronic condition affecting 1 in 100 people in the UK today, causing the immune system to attack its joints. Unlike osteoarthritis, which is caused by wear and tear, RA can... Read more

Pathology

view channel
Image: A tool uses artificial intelligence and high-resolution imaging to track senescent cells (Courtesy of Adobe Stock)

AI-Assisted Technique Tracks Cells Damaged from Injury, Aging and Disease

Senescent cells, which stop growing and reproducing due to injury, aging, or disease, play a critical role in wound repair and aging-related diseases like cancer and heart disease. These cells, however,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.